Locations:
Search IconSearch
April 11, 2019/Neurosciences

Innovative Autism Research Focused on Sleep Techniques and Behavioral Interventions Draws $8M DoD Grants

15-NEU-2677-Frazier-650×450

The U.S. Department of Defense has awarded a Cleveland Clinic Children’s researcher two, four-year grants to support innovative clinical trials for young children with autism spectrum disorder.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cynthia Johnson, PhD, Director of Cleveland Clinic Children’s Center for Autism, is principal investigator of both studies.

Evaluating the efficacy of 2 parent-focused programs

The first study, a four-year, $1 million grant directed by Dr. Johnson, will evaluate the efficacy of two parent-focused programs – the Sleep Parent Training program (SPT) and the Parent Educational Program (PEP) – both delivered via the Cleveland Clinic Express Care Online app.

The Sleep Parent Training program is modeled after a behavior parent-training program developed by Johnson. Through this randomized trial, parents are provided practical tools and suggestions for improving the child’s bedtime routine, such as self-soothing techniques. The Parent Educational Program provides useful information about the child’s diagnosis and information about accessing services for the child.

The sleep study will involve 90 patients with autism spectrum disorder between the ages 2 and 7 who have a significant sleep disturbance.

“Both programs will be offered through the Cleveland Clinic Express Care telehealth platform over the span of five sessions, which allows us to reach more families and gives more scheduling flexibility,” Dr. Johnson says. “With this approach, we’ll be able to coach the parents at a time that is convenient for them, such as at dinnertime or right before the bedtime routine.”

This research will build upon a previous NIH-funded pilot study, led by Johnson at the University Of Pittsburgh School of Medicine, that observed favorable sleep outcomes with the behavior parent-training program.

Advertisement

Comparing the effectiveness of EIBI and ABA

In addition to the sleep study, the Department of Defense also has awarded Cleveland Clinic Children’s Center for Autism, and four collaborating institutions nationwide, a four-year, $7 million grant to study the comparative effectiveness of early intensive behavior intervention (EIBI) with less intensive, time-limited, applied behavior analysis (ABA) for young children affected by autism spectrum disorder. Key child and parent outcomes will be compared at three time points during the 24 weeks of intervention, at follow-up and at 5 years of age.

The data coordinating center for this study is the University Of Rochester School Of Medicine. Johnson and her team at Cleveland Clinic Children’s Center for Autism will collaborate with co-investigators at May Institute (Randolph, Mass.), Nationwide Children’s Hospital (Columbus, Ohio), and Vanderbilt University Medical Center (Nashville, Tenn.).

The study plans to recruit a total of 130 children, between the ages of 2 to 5, across the collaborative network, of which 33 will be enrolled at Cleveland Clinic Children’s Center for Autism.

Advertisement

Related Articles

woman in red shirt standing beside a sign for clinical study recruitment
February 20, 2025/Neurosciences/Research
The Cleveland Clinic Brain Study at 3 Years: Initial Insights, Surprises and Next Steps

A principal investigator of the landmark longitudinal study shares interesting observations to date

intracranial hemorrhage in the basal ganglia as shown on a brain scan
February 19, 2025/Neurosciences/Cerebrovascular
Novel Imaging Model of Basal Ganglia ICH Predicts Outcomes After Minimally Invasive Surgical Evacuation

Results may refine surgical selection criteria and advance clinical trial design

Dr. Wint against a decorative background.
February 17, 2025/Neurosciences/Podcast
Managing Psychological Symptoms of Dementia (Podcast)

Depression, agitation, delusions and more compound challenges for patients and caregivers

DNA double helix superimposed on transparent human brain
Researchers Identify Potential Risk Genes and Drug Repurposing Candidates in Parkinson’s Disease

Systems genetics approach sets stage for lab testing of simvastatin and other candidate drugs

bottle of liquid cannabidiol next to a medicine dropper
February 11, 2025/Neurosciences/Epilepsy
CBD Yields Rapid Seizure Resolution in Two Cases of Refractory Epilepsy With Myoclonic-Atonic Seizures

Sustained remission of seizures and neurocognitive dysfunction subsequently maintained with cannabidiol monotherapy

Dr. Rebecca Kuenzler against a decorative background
February 3, 2025/Neurosciences/Podcast
Contemporary Care of Amyotrophic Lateral Sclerosis (Podcast)

Modest research progress to date can still be turned into meaningful patient gains

middle-aged woman with surgical mask looking out a window
Registry Studies Reassure on Impact of COVID-19 in People With MS

No effect on symptom severity or disability, and low prevalence of long COVID

network of nerves on the side of the face
January 14, 2025/Neurosciences/Brain Tumor
Preemptive Facial Nerve Rewiring in the Management of Facial Nerve Tumor: A Case Study

Novel approach begins reinnervation before tumor resection, preserving a young woman’s smile

Ad